Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues - PubMed (original) (raw)
Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues
X M Guan et al. Brain Res Mol Brain Res. 1997 Aug.
Abstract
Growth hormone release is under tight control by two hypothalamic hormones: growth hormone-releasing hormone and somatostatin. In addition, synthetic growth hormone secretagogues have also been shown to regulate growth hormone release through the growth hormone secretagogue receptor (GHS-R), suggesting the existence of an additional physiological regulator for growth hormone release. To understand the physiological role of the GHS-R in more detail, we mapped the expression of mRNA for the receptor by in situ hybridization and RNase protection assays using rat and human tissues. In the rat brain, the major signals were detected in multiple hypothalamic nuclei as well as in the pituitary gland. Intense signals were also observed in the dentate gyrus of the hippocampal formation. Other brain areas that displayed localized and discrete signals for the receptor include the CA2 and CA3 regions of the hippocampus, the substantia nigra, ventral tegmental area, and dorsal and median raphe nuclei. In resemblance to the results from rat brain, RNase protection assays using human tissues revealed specific signals in pituitary, hypothalamus and hippocampus. Moreover, a weak signal was noted in the pancreas. The demonstration of hypothalamic and pituitary localization of the GHS-R is consistent with its role in regulating growth hormone release. The expression of the receptor in other central and peripheral regions may implicate its involvement in additional as yet undefined physiological functions.
Similar articles
- Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.
McKee KK, Palyha OC, Feighner SD, Hreniuk DL, Tan CP, Phillips MS, Smith RG, Van der Ploeg LH, Howard AD. McKee KK, et al. Mol Endocrinol. 1997 Apr;11(4):415-23. doi: 10.1210/mend.11.4.9908. Mol Endocrinol. 1997. PMID: 9092793 - Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogue receptor (GHS-R) mRNA levels during postnatal development in male and female rats.
Kamegai J, Wakabayashi I, Kineman RD, Frohman LA. Kamegai J, et al. J Neuroendocrinol. 1999 Apr;11(4):299-306. doi: 10.1046/j.1365-2826.1999.00330.x. J Neuroendocrinol. 1999. PMID: 10223284 - Growth hormone secretagogue actions on the pituitary gland: multiple receptors for multiple ligands?
Chen C. Chen C. Clin Exp Pharmacol Physiol. 2000 May-Jun;27(5-6):323-9. doi: 10.1046/j.1440-1681.2000.03258.x. Clin Exp Pharmacol Physiol. 2000. PMID: 10831231 Review. - Structure and regulation of the growth hormone secretagogue receptor.
Petersenn S. Petersenn S. Minerva Endocrinol. 2002 Dec;27(4):243-56. Minerva Endocrinol. 2002. PMID: 12511847 Review.
Cited by
- Therapeutic potential of ghrelin/GOAT/GHSR system in gastrointestinal disorders.
Ma Y, Yan Q, Wang P, Guo W, Yu L. Ma Y, et al. Front Nutr. 2024 Aug 23;11:1422431. doi: 10.3389/fnut.2024.1422431. eCollection 2024. Front Nutr. 2024. PMID: 39246401 Free PMC article. Review. - GHSR blockade, but not reduction of peripherally circulating ghrelin via β1-adrenergic receptor antagonism, decreases binge-like alcohol drinking in mice.
Richardson RS, Kryszak LA, Vendruscolo JCM, Koob GF, Vendruscolo LF, Leggio L. Richardson RS, et al. Mol Psychiatry. 2024 Sep 5. doi: 10.1038/s41380-024-02713-3. Online ahead of print. Mol Psychiatry. 2024. PMID: 39232198 - Acyl modifications in bovine, porcine, and equine ghrelins.
Ida T, Tominaga H, Iwamoto E, Kurogi A, Okura A, Shimada K, Kato J, Kuwano A, Ode H, Nagata S, Kitamura K, Yazawa T, Sato-Hashimoto M, Yasuda M, Miyazato M, Shiimura Y, Sato T, Kojima M. Ida T, et al. Front Endocrinol (Lausanne). 2024 May 17;15:1411483. doi: 10.3389/fendo.2024.1411483. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38828411 Free PMC article. - Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trial.
Hernández-Bernal F, Estenoz-García D, Gutiérrez-Ronquillo JH, Martín-Bauta Y, Catasús-Álvarez K, Gutiérrez-Castillo M, Guevara-Rodríguez M, Castro-Jeréz A, Fuentes-González Y, Pinto-Cruz Y, Valenzuela-Silva C, Muzio-González VL, Pérez-Saad H, Subirós-Martínez N, Guillén-Nieto GE, Garcia-Del-Barco-Herrera D. Hernández-Bernal F, et al. Front Neurol. 2024 Apr 4;15:1303402. doi: 10.3389/fneur.2024.1303402. eCollection 2024. Front Neurol. 2024. PMID: 38638315 Free PMC article. - Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trial.
Pietrzak M, Yngve A, Hamilton JP, Asratian A, Gauffin E, Löfberg A, Gustavson S, Persson E, Capusan AJ, Leggio L, Perini I, Tinghög G, Heilig M, Boehme R. Pietrzak M, et al. Neuropsychopharmacology. 2024 May;49(6):1042-1049. doi: 10.1038/s41386-024-01821-6. Epub 2024 Feb 26. Neuropsychopharmacology. 2024. PMID: 38409282 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous